About CRI

Jedd D. Wolchok, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center and Ludwig Cancer Research
New York, NY

Dr. Wolchok is director of Immunotherapeutics, Center for Mechanism Based Therapy at Memorial Sloan Kettering Cancer Center, an associate director of the Ludwig Center for Cancer Immunotherapy at MSKCC, an associate member of the Ludwig Cancer Research, and the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation at MSKCC. He is director of the CRI/Ludwig Cancer Vaccine Collaborative, and is a member of the CRI Scientific Advisory Council. He is also the co-director of the Swim Across America laboratory at MSKCC, one of the foremost immunotherapy and melanoma research groups in the country.

His specific research interest is the pre-clinical and early clinical development of novel immunologic therapies. Most recently, Dr. Wolchok has initiated several clinical trials using plasmid DNA vaccines for patients with melanoma. He has been involved in the development of the DNA vaccine program at every level--from initial studies in mouse models, through all levels of regulatory review, and now as principal investigator of the clinical trials.

Dr. Wolchok has authored numerous articles concerning DNA vaccines, cytokine biology, and clinical care of melanoma and co-authored two chapters in the definitive textbook, Cutaneous Melanoma. Dr. Wolchok is also co-editor of the journal Cytotherapy.